Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • India 2047: Paving the Path to a Climate-Resilient Future: Harvard Joins MoEFCC for Key Conference National
  • Urjasvini Special School: The Best Special School in Indore Education
  • Exclusive Recognition: National Business Ratna Award 2025 Business
  • Delhi Police Enhances Traffic Surveillance with Installation of Automatic Number Plate Recognition (ANPR) Software National
  • Shreeji Shipping Registers Robust Q2 FY26 Performance; Profit Margin Rises by 325 bps Business
  • Herry Shroti: The Entrepreneur Who Proves that Success and Selflessness Can Coexist   Business
  • KalonGens, Start-up by Former Boxer Keshav, provides Unbeatable Talent-Powered Solutions For Advance Business Success Business
  • Hadh Kar Di Aapne turns 25: The comedy classic with a lasting legacy Entertainment

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Best Health Experts in India Advice on Gynecologic & Blood Cancers Health
  • Sarvodaya Hospital Performs Youngest Cochlear Implant On 5-Month-Old Baby In India Health
  • Aarthi Scans and Labs Revolutionizes Indian Diagnostics Industry with 50 Percent Price Reduction on Essential Diagnostic Tests Health
  • Spandan Heart Care Clinic Unlocks the Power of EECP Therapy (Natural Bypass Therapy) for Heart Health Health
  • World Heart Day 2025: Heart Disease on the Rise Amongst Young—Why Waiting Is Dangerous Health
  • Divyamrut Ayurcare : Kerala Ayurveda’s Healing Power Now Available in Mumbai Health

Recent Posts

  • Rahul Kanuganti: Redefining Logistics Through Energy Planning
  • Beyond Compliance: How Surat’s Earth Day Drive Brought India’s BRSR and EPR Frameworks to Life
  • BNI Ahmedabad to host Symposium 2026, bring together 10,000+ business leaders
  • Pajson Agro Reports Robust 37% Revenue Growth to Rs 256.92 Crore in FY26
  • Digikore Studios Delivers Blockbuster FY26 Results, Revenue Surges 83.1% to Rs 66.02 Crore, PAT at Rs 12.64 Crore, Net Worth Rises 37.1% to Rs 47.68 Crore

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • INHERITCOIN Joins the League of Cryptocurrencies Leveraging Ethereum blockchain Business
  • PINNACLE Air Bids for retail travel business of Future Retail Business
  • Ganesh Chaturthi made special with Chef Ranveer Brar and MILKMAID! Lifestyle
  • Dabur Honey: A Healthy Alternative to Sugar Health
  • EXCHANGE22 bags Primary Sponsorship Rights in India Tour of Ireland T20 Series Business
  • The father-son duo Suneek Jain and Keshav Jain taking their family business ‘KTTINC’ on a new level Business
  • TSM TheSafetyMaster Pvt Ltd: India’s Leading Safety Consultant Business
  • Deco-Arte creating Avante Garde spaces making their clients live luxuriously Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme